BOOKS BY CATEGORY
Your Account
Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy
Price
Quantity
€170.79
(To see other currencies, click on price)
Paperback / softback
Add to basket  

MORE ABOUT THIS BOOK

Main description:

This book reviews the latest developments in the design, synthesis, and molecular mechanism of action of Histone Deacetylase (HDAC) inhibitors in the context of potential cancer therapy. HDAC inhibitors are emerging as promising anticancer drug molecules that promote growth arrest, differentiation and apoptosis of cancer cells with tumor selective toxicity.

The book begins with an overview of various epigenetic modifying enzymes that are involved in cancer transition and progression; before exploring the potential of HDACs in cancer treatment. It provides a classification of HDAC inhibitors based on their structural attributes, and addresses HDAC-induced cytotoxicity..

Lastly, it discusses and assesses the rationale behind therapies that combine HDAC inhibitors with other anticancer agents to treat solid tumors. Given its scope, it offers a valuable resource for all researchers, clinicians, and students working in formulation, drug discovery, oncology, and personalized medicine.


PRODUCT DETAILS

ISBN-13: 9789811581816
Publisher: Springer (Springer Verlag, Singapore)
Publication date: November, 2021
Pages: 258
Weight: 427g
Availability: Available
Subcategories: Biochemistry, Genetics, Oncology

CUSTOMER REVIEWS

Average Rating